If lawmakers want lower drug prices, they should strengthen competitive pressure, not regulate it into passivity. The politics are easy to understand. Attacking middlemen polls well. It allows lawmakers to appear tough on prices without directly confronting manufacturers. But the economics are less forgiving. Lower drug prices require bargaining power. Congress has just reduced it. Patients and taxpayers will bear the cost.
南方周末：当前未成年人对网络的接触频率高，相关未成年人涉网络犯罪有何特点？可否举些典型案例？
，这一点在PDF资料中也有详细论述
10 monthly gift articles to share。关于这个话题，PDF资料提供了深入分析
Платон Щукин (Редактор отдела «Экономика»)